The Trump administration’s export-control licensing regime is achieving little strategic benefit while costing the United States billions of dollars in lost exports and undermining American companies’ global market share, according to a new business survey.“Months-long licensing delays are costing the United States billions of dollars in exports and eroding American market share globally,” the US-China Business Council (USCBC) found in a flash survey of companies conducted in July.The survey also found that most of the pending export licences are for items that are “already available in China from Chinese or international suppliers – effectively sidelining American companies for no strategic gain”.USCBC is a non-profit association of around 270 American companies that conduct business in China. The latest flash survey covered 31 companies from the technology, industrial and manufacturing, energy, and healthcare sectors.11:24How does Trump’s latest fallout with traditional allies play into Beijing’s hands?
US export controls achieving no strategic gain, hurting American firms: survey
US’ export-control licensing regime costs billions in lost exports, with items ‘already available in China’ from variety of other suppliers.
TL;DRAI
USCBC survey: Trump export controls cost billions with zero strategic benefit—restricted items already available from Chinese competitors, eroding US market share. Tech leaders accelerate vendor diversification away from US solutions amid rising compliance friction.
143 words~1 min read
